151 related articles for article (PubMed ID: 10713073)
1. Purification and characterization of a magnesium-dependent neutral sphingomyelinase from bovine brain.
Bernardo K; Krut O; Wiegmann K; Kreder D; Micheli M; Schäfer R; Sickman A; Schmidt WE; Schröder JM; Meyer HE; Sandhoff K; Krönke M
J Biol Chem; 2000 Mar; 275(11):7641-7. PubMed ID: 10713073
[TBL] [Abstract][Full Text] [Related]
2. Purification and characterization of a membrane bound neutral pH optimum magnesium-dependent and phosphatidylserine-stimulated sphingomyelinase from rat brain.
Liu B; Hassler DF; Smith GK; Weaver K; Hannun YA
J Biol Chem; 1998 Dec; 273(51):34472-9. PubMed ID: 9852115
[TBL] [Abstract][Full Text] [Related]
3. Identification of three competitive inhibitors for membrane-associated, Mg2+-dependent and neutral 60 kDa sphingomyelinase activity.
Kim SK; Jung SM; Ahn KH; Jeon HJ; Lee DH; Jung KM; Jung SY; Kim DK
Arch Pharm Res; 2005 Aug; 28(8):923-9. PubMed ID: 16178418
[TBL] [Abstract][Full Text] [Related]
4. Purification and characterization of neutral sphingomyelinase from Helicobacter pylori.
Chan EC; Chang CC; Li YS; Chang CA; Chiou CC; Wu TZ
Biochemistry; 2000 Apr; 39(16):4838-45. PubMed ID: 10769141
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biochemical investigation of scyphostatin analogues as inhibitors of neutral sphingomyelinase.
Arenz C; Gartner M; Wascholowski V; Giannis A
Bioorg Med Chem; 2001 Nov; 9(11):2901-4. PubMed ID: 11597471
[TBL] [Abstract][Full Text] [Related]
6. Neutral sphingomyelinase activity dependent on Mg2+ and anionic phospholipids in the intraerythrocytic malaria parasite Plasmodium falciparum.
Hanada K; Mitamura T; Fukasawa M; Magistrado PA; Horii T; Nishijima M
Biochem J; 2000 Mar; 346 Pt 3(Pt 3):671-7. PubMed ID: 10698693
[TBL] [Abstract][Full Text] [Related]
7. Neutral sphingomyelinase inhibitor scyphostatin prevents and ceramide mimics mechanotransduction in vascular endothelium.
Czarny M; Schnitzer JE
Am J Physiol Heart Circ Physiol; 2004 Sep; 287(3):H1344-52. PubMed ID: 15142848
[TBL] [Abstract][Full Text] [Related]
8. Neutral magnesium-dependent sphingomyelinase from liver plasma membrane: purification and inhibition by ubiquinol.
Martín SF; Navarro F; Forthoffer N; Navas P; Villalba JM
J Bioenerg Biomembr; 2001 Apr; 33(2):143-53. PubMed ID: 11456220
[TBL] [Abstract][Full Text] [Related]
9. Identification of neutral and acidic sphingomyelinases in Helicobacter pylori.
Lin YL; Liu JS; Chen KT; Chen CT; Chan EC
FEBS Lett; 1998 Feb; 423(2):249-53. PubMed ID: 9512367
[TBL] [Abstract][Full Text] [Related]
10. Effects of gentamicin on sphingomyelinase activity in cultured human renal proximal tubular cells.
Ghosh P; Chatterjee S
J Biol Chem; 1987 Sep; 262(26):12550-6. PubMed ID: 3040755
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the neutral magnesium-dependent sphingomyelinase by glutathione.
Liu B; Hannun YA
J Biol Chem; 1997 Jun; 272(26):16281-7. PubMed ID: 9195931
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the neutral pH-optimum sphingomyelinase from rat brain: inhibition by copper II and ganglioside GM3.
Lister MD; Crawford-Redick CL; Loomis CR
Biochim Biophys Acta; 1993 Jan; 1165(3):314-20. PubMed ID: 8418889
[TBL] [Abstract][Full Text] [Related]
13. Identification of multiple forms of membrane-associated neutral sphingomyelinase in bovine brain.
Jung SY; Suh JH; Park HJ; Jung KM; Kim MY; Na DS; Kim DK
J Neurochem; 2000 Sep; 75(3):1004-14. PubMed ID: 10936181
[TBL] [Abstract][Full Text] [Related]
14. Phosphatidylinositol-3,5-Bisphosphate is a potent and selective inhibitor of acid sphingomyelinase.
Kölzer M; Arenz C; Ferlinz K; Werth N; Schulze H; Klingenstein R; Sandhoff K
Biol Chem; 2003 Sep; 384(9):1293-8. PubMed ID: 14515991
[TBL] [Abstract][Full Text] [Related]
15. Entamoeba histolytica: molecular cloning and characterization of a novel neutral sphingomyelinase.
Mendoza-Macías CL; Barrios-Ceballos MP; Anaya-Velázquez F; Nakada-Tsukui K; Nozaki T; Padilla-Vaca F
Exp Parasitol; 2010 Jul; 125(3):279-85. PubMed ID: 20138872
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of tumor necrosis factor-induced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase.
Luberto C; Hassler DF; Signorelli P; Okamoto Y; Sawai H; Boros E; Hazen-Martin DJ; Obeid LM; Hannun YA; Smith GK
J Biol Chem; 2002 Oct; 277(43):41128-39. PubMed ID: 12154098
[TBL] [Abstract][Full Text] [Related]
17. Neutral sphingomyelinase from human urine. Purification and preparation of monospecific antibodies.
Chatterjee S; Ghosh N
J Biol Chem; 1989 Jul; 264(21):12554-61. PubMed ID: 2545711
[TBL] [Abstract][Full Text] [Related]
18. Purification of a newly identified alkaline sphingomyelinase in human bile and effects of bile salts and phosphatidylcholine on enzyme activity.
Duan RD; Nilsson A
Hepatology; 1997 Oct; 26(4):823-30. PubMed ID: 9328299
[TBL] [Abstract][Full Text] [Related]
19. Ceramide and sphingomyelinases in the regulation of stress responses.
Sawai H; Hannun YA
Chem Phys Lipids; 1999 Nov; 102(1-2):141-7. PubMed ID: 11001568
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning, characterization, and expression of a novel human neutral sphingomyelinase.
Chatterjee S; Han H; Rollins S; Cleveland T
J Biol Chem; 1999 Dec; 274(52):37407-12. PubMed ID: 10601312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
